Health Canada Medical Device Licence Evidence Map — MDALL similar-device, class clues, and market-entry research
Start with the device. Then map the public Health Canada evidence around it. The Canada view of the Medical Device Product Evidence Map organizes candidate Class I / II / III / IV clues, Medical Device Licence records, similar-licensed-device landscape from MDALL, licence-holder landscape, Canada recall and safety-alert history, application-checklist references, and labelling comparisons around your product family. The output is source-backed evidence and candidate review points for qualified RA/QA or consultant review — never a regulatory determination.
For founders, manufacturers, RA/QA teams, and regulatory consultants. For RA/QA or consultant review.
This is not regulatory, legal, or compliance advice. TrueMedDevice does not determine device class, MDL/MDEL eligibility, licence outcome, compliance, safety, or effectiveness. We organize public Health Canada and MDALL sources so qualified RA/QA professionals or regulatory consultants can review and decide.
What should I check before applying for a Health Canada medical device licence?
Before applying for a Medical Device Licence (MDL), organize candidate Class I / II / III / IV clues under SOR/98-282 Schedule 1, MDL vs MDEL applicability research, a similar- licensed-device shortlist from MDALL, a Canada safety-history scan, candidate guidance / application-checklist references, MDSAP / ISO 13485 documentation references, and your own written open questions. The Canada view of the Product Evidence Map below organizes these into a single product- centered interface.
How do I find similar licensed devices in Canada?
MDALL (the Medical Devices Active Licence Listing) is Health Canada's public registry of medical devices currently or formerly licensed under SOR/98-282. Search MDALL by device name, manufacturer, licence number, or class to surface candidate similar-licensed devices. Build a comparison covering intended purpose, technological characteristics, and labelling. The candidate similar-licensed-device shortlist is research output for RA/QA review — never a Health Canada determination about your candidate device.
For the broader Canada licence pathway research workflow, see the open-access Health Canada Medical Device Licence Research Guide.
What public evidence should be organized before a Health Canada consultant conversation?
Nine public-source Canada evidence areas commonly carry the most signal: candidate device-class clues, MDL records, similar-licensed-device landscape, MDALL / licence-holder landscape, recall and safety-alert history, candidate guidance / application-checklist clues, labelling / intended- use comparison, consultant-prep questions, and the deliverable Health Canada Product Family Evidence Pack. Each is rendered as an interactive evidence area in the Canada view of the Product Evidence Map below — click any area to read its meaning, why it may matter, the public sources commonly reviewed, what TrueMedDevice can prepare as candidate review points, and the relevant boundary language.
Canada / Health Canada view
Map public Health Canada evidence around your medical device product family.
Start with the device. Then map the candidate class, similar-licensed-device landscape, MDALL / licence-holder landscape, Canada safety-history, application-checklist, and consultant-prep evidence around it.
This is not regulatory, legal, or compliance advice. TrueMedDevice does not determine device class, MDL/MDEL eligibility, licence outcome, compliance, safety, or effectiveness. We organize public-source evidence and prepare candidate review points so qualified RA/QA professionals or regulatory consultants can review and decide.
Center · Your product family
Your Product Family
Start with the device. Then map the public evidence around it.
Ring 0 — Product facts
Inputs about the device- Intended useOne-sentence statement of what the device is for.
- Indications / claimsPopulation, condition, or context the device is indicated for.
- Technology characteristicsPrinciple of operation, energy used, key materials, sensors, algorithms.
- Target usersClinician, technician, patient, lay caregiver — and where applicable, training requirements.
- Use environmentHospital, clinic, home, ambulance, mobile, sterile field, etc.
- Software / connectivityOn-device software, cloud connectivity, cybersecurity scope, interoperability.
- Accessories / componentsDisposables, sensors, leads, sterilization-sensitive parts, packaging.
- Target marketU.S. / FDA, Canada / Health Canada, or both. Phasing if both.
- Comparable productsWorking list of similar marketed devices already known to the team.
The center captures the device. The evidence areas below capture the public-source evidence TrueMedDevice can organize around it.
Ring 1 — Evidence areas
Canada / Health Canada evidence areas
Click any evidence area to expand its meaning, why it may matter, which public sources are commonly reviewed, and what TrueMedDevice can prepare as candidate review points for qualified RA/QA review.
Review output — Next step
Hand the evidence to qualified RA/QA or consultant review
TrueMedDevice provides public-source research and evidence organization support. This page and any related Evidence Pack do not determine device classification, predicate suitability, regulatory pathway, licence route, clearance likelihood, compliance status, reportability, or legal/regulatory obligations. Final decisions remain with the company's qualified RA/QA, regulatory, legal, or consultant professionals.
Boundary: This is not regulatory, legal, or compliance advice. TrueMedDevice does not determine device class, MDL/MDEL eligibility, licence outcome, compliance, safety, or effectiveness. We organize public-source evidence and prepare candidate review points so qualified RA/QA professionals or regulatory consultants can review and decide.
What the Canada view of the Product Evidence Map surfaces
For Canada / Health Canada market-entry research, the map surfaces a consistent set of public-source evidence areas around a candidate device family — never a regulatory determination:
- Device class clues — candidate Class I / II / III / IV indications under the risk-based rules in SOR/98-282 Schedule 1.
- Medical Device Licence records — MDL entries for similar marketed devices in Canada with licence number, applicant, class, and current status.
- Similar licensed devices — direct and indirect similar-licensed devices from MDALL with intended-purpose and technological-characteristics notes for RA/QA review.
- MDALL / licence-holder landscape — the set of Canadian licence holders for the candidate device category, including candidate MDEL applicability context for the firm's supply-chain role.
- Recall and safety-alert history — Health Canada Recalls and Safety Alerts, Public Advisories, Foreign Risk Notifications, and Medical Device Incident Reports under Canada Vigilance for the candidate similar-licensed-device set.
- Guidance and application-checklist clues — Health Canada guidance, MDL application guidance, and MDSAP / ISO 13485 documentation references for the candidate class.
- Consultant-prep questions — an open-questions packet built from the evidence-area scan for the first paid Canadian consultant call.
Each evidence area renders as an interactive card above. Every output is a candidate review point for qualified RA/QA or consultant review — sourced and dated.
What the Canada Product Evidence Map does not determine
The map organizes public-source Health Canada and MDALL evidence. It does not determine:
- Device class under SOR/98-282 — final class is Health Canada's call when a licence application is reviewed.
- MDL/MDEL eligibility — applicability of a Medical Device Licence or Medical Device Establishment Licence is a manufacturer-and-RA/QA determination prepared with Canadian consultant input.
- Licence route or licence outcome — neither the route to licence nor whether a licence will issue is inferred or scored by the map.
- Compliance status or reportability — none of these are inferred, predicted, or asserted by the map.
- Safety or effectiveness — neither for the candidate device nor for any device in the similar-licensed- device landscape.
Final decisions remain with the company's qualified RA/QA, regulatory, legal, or consultant professionals in consultation with Health Canada.
Why product-centered evidence mapping helps before a Canadian consultant conversation
Canadian regulatory research that starts with a checklist tends to drift. Research that starts with the device, then maps the public Health Canada and MDALL evidence around it, keeps the candidate device at the center of the conversation. Candidate device-class clues lead to similar licensed devices in MDALL; the similar-licensed-device shortlist frames the intended- purpose comparison; the Canada safety-history scan focuses on what has actually been observed in this product family.
By the time the first paid Canadian consultant call begins, the qualified RA/QA team or consultant is reviewing source-cited candidate review points — not assembling them. The consultant spends the hour on judgment, not on retrieval.
Related Canada research
- Health Canada Medical Device Licence Research Guide — what to prepare before MDL/MDEL application discussions
- Medical Device Safety-History Scan Before Market Entry — public-source review-point playbook
- Prepare for Your First Regulatory Consultant Meeting — eight-block checklist
- Canada / Health Canada Market-Entry Product Evidence Pack — the service that ships the artifacts above
- What is inside a Market-Entry Product Evidence Pack — one-page overview
- Request a Product ID intake — start the Canada research on your device
Frequently asked questions
What should I check before applying for a Health Canada medical device licence?
Before applying for a Medical Device Licence (MDL), gather a written intended-purpose statement, candidate Class I / II / III / IV clues with rule citations under SOR/98-282 Schedule 1, MDL vs MDEL applicability research, a similar-licensed-device shortlist from MDALL with licence numbers and class, a Canada safety-history scan (Recalls and Safety Alerts, Public Advisories, Foreign Risk Notifications, Medical Device Incident Reports under Canada Vigilance), a candidate application-checklist reference, MDSAP / ISO 13485 documentation references, and your own list of open questions. The Canada view of the Product Evidence Map organizes these public-source evidence areas around your product family. Final class, MDL/MDEL eligibility, licence outcome, and submission strategy decisions remain with qualified RA/QA professionals or qualified Canadian consultants in consultation with Health Canada.
How do I find similar licensed devices in Canada?
MDALL (the Medical Devices Active Licence Listing) is Health Canada's public registry of medical devices currently or formerly licensed under SOR/98-282. Search MDALL by device name, manufacturer, licence number, or class to surface direct and indirect similar-licensed devices with licence numbers, applicants, classes, and current status. Build a candidate similar-licensed-device shortlist with source-cited notes on intended purpose, technological characteristics, and labelling. The Canada view of the Product Evidence Map below renders this as an interactive evidence area.
What public evidence should be organized before a Health Canada consultant conversation?
Nine public-source Canada evidence areas commonly carry the most signal before the consultant call: candidate device-class clues, Medical Device Licence (MDL) records, similar-licensed-device comparison, MDALL / licence-holder landscape, Canada recall and safety-alert history, candidate guidance / application-checklist clues, labelling / intended-purpose comparison, consultant-prep questions, and the compiled Health Canada Product Family Evidence Pack. The Canada view of the Product Evidence Map renders each as an interactive evidence area with public sources, candidate review points, and the relevant boundary language.
Does the Product Evidence Map determine my Health Canada device class or licence route?
No. The Product Evidence Map surfaces candidate device-class clues and a similar-licensed-device landscape from MDALL, but it does not determine device class, MDL/MDEL eligibility, licence outcome, compliance, safety, or effectiveness. Those are Health Canada determinations that the manufacturer's qualified RA/QA team and qualified Canadian consultant team prepare for. The map's outputs are inputs for qualified RA/QA or consultant review.
Is MDSAP required for a Health Canada Medical Device Licence?
Health Canada requires manufacturers of Class II, III, and IV devices to hold an MDSAP (Medical Device Single Audit Program) certificate covering ISO 13485:2016 as part of the MDL application package. MDSAP audit scope, eligibility, and certification outcomes are determined by MDSAP-recognized Auditing Organizations and Health Canada. The Canada view of the Product Evidence Map surfaces the documentation context as candidate review points; it does not determine MDSAP scope or licence outcome.
Want this Canada research run on your product?
The Canada / Health Canada Market-Entry Product Evidence Pack delivers the nine evidence areas above — candidate device-class clues, MDL/MDEL applicability research, similar-licensed-device shortlist from MDALL, Canada safety-history scan, application- checklist reference, MDSAP / ISO 13485 documentation reference, source ledger, and consultant briefing sheet — as a source-cited artifact for qualified RA/QA or qualified Canadian consultant review.
Request a Health Canada Product Family Evidence PackThis is not regulatory, legal, or compliance advice. TrueMedDevice does not determine device class, MDL/MDEL eligibility, licence outcome, compliance, safety, or effectiveness. We prepare a source-backed Health Canada / MDALL / public-source evidence pack so qualified RA/QA professionals or regulatory consultants can review and decide.
TrueMedDevice provides public-source research and evidence organization support. This page does not determine device class, licence route, MDL/MDEL eligibility, licence outcome, compliance status, reportability, or legal/regulatory obligations. Final decisions remain with the company's qualified RA/QA, regulatory, legal, or consultant professionals. We prepare source-backed evidence and candidate review points for review.